Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A widely prescribed type of medication for the management of type 2 diabetes may also help reduce the risk of developing an eye condition that can lead to vision loss
In December 2025, Sun Pharma received DCGI approval for manufacturing and marketing semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
GLP-1 medications are synthetic versions of the natural GLP-1 hormone
[1] [2] The incidence of these effects increased with higher doses, consistent with the dose-dependent pharmacology of GLP-1 receptor agonists as a class
Over a year, thats 32,850 calories, equivalent to 9.4 pounds of potential fat regain
Semaglutides ability to help manage weight is particularly important for people with health conditions related to being overweight, such as high blood pressure or diabetes
